One Medical review

One Medical offers two routes rather than one fixed subscription. On-Demand Care is a cash-pay telehealth option advertised from $39 per weight-loss treatment. It does not accept insurance or handle prior authorizations. The fee covers clinician review and 14 days of follow-up messaging after the care summary; medication and laboratory testing are explicitly excluded. After that message window, another treatment request may be necessary for further questions or adjustments, so $39 should not be interpreted as a complete monthly cost. Scheduled Visits are the primary-care route. They may be in person or remote, are billed to the patient or insurance, and can include lab orders, monitoring, and prior-authorization work. Copays, deductibles, or self-pay charges depend on the plan and location. A One Medical membership is not required to enter the GLP-1 program. Optional membership costs $199 per year at the standard rate; Prime members can currently pay $9 per month or $99 per year. Membership includes selected on-demand services but does not make scheduled visits or prescriptions free. Amazon Pharmacy advertises oral medication from $149 monthly and injectables from $299 monthly. These are conditional starting prices, not guaranteed totals. The drug, insurance coverage, manufacturer coupon eligibility, labs, and visit frequency determine the real ongoing cost.

The current program page lists oral and injectable semaglutide under the Wegovy brand, injectable tirzepatide under Zepbound—including its auto-injector and KwikPen presentations—and oral orforglipron under the Foundayo brand. FDA sources confirm that these named products are approved prescription drugs for weight reduction or long-term weight management in qualifying adults. Tirzepatide acts on both GIP and GLP-1 receptors, although it is commonly grouped with GLP-1 weight-loss treatments. This is not a compounded-medication program. One Medical explicitly states that its On-Demand Care clinicians will not prescribe compounded GLP-1 medication. It says a clinician may help someone already using a compounded product transition to a standard product that can be dispensed by a conventional pharmacy. FDA guidance separately emphasizes that compounded drugs are not FDA-approved and do not undergo the agency’s premarket review for safety, effectiveness, or quality. A prescription is not guaranteed. A licensed clinician determines whether medication is appropriate and which product fits the patient’s history and preferences. Prescriptions can be sent to the patient’s chosen pharmacy; Amazon Pharmacy is optional. Because drug availability, insurance formularies, coupon programs, and approved presentations can change, readers should verify the exact brand and form on both the prescription and dispensed package. This review provides no dosing or treatment recommendation.

One Medical frames the program as clinician-managed weight care rather than pharmacy access alone. Its scheduled pathway starts with screening and a structured consultation, followed by regular visits, monitoring, and treatment changes within a broader primary-care relationship. The company says clinicians consider cardiovascular health, diabetes, and other metabolic conditions instead of treating weight as an isolated issue. One Medical’s weight-loss service is staffed by physicians, nurse practitioners, and physician assistants, although a patient’s assigned clinician and credentials will vary. The cash-pay On-Demand pathway is more limited. Its page describes a health intake, review by a licensed clinician, a personalized care summary, and 14 days of messaging with the next available provider for questions, side effects, prescription problems, or possible adjustments. A new paid treatment request may be required after 14 days. On-Demand Care requires recent kidney-function and blood-sugar laboratory results; purchasing those tests is the patient’s responsibility when results are unavailable. The online page presents this route for adults ages 18–64 who meet its screening conditions and do not have diabetes. Scheduled primary care may be more appropriate when insurance authorization or closer monitoring is needed. One official launch article emphasizes on-demand renewals for people with existing prescriptions, while the current program page appears to support evaluated new starts. Readers should confirm which use case their selected checkout flow currently accepts.

Start by entering your state or ZIP code on the official weight-loss page. Amazon says its pharmacy ships the listed medications to all 50 states, but that is not the same as nationwide access to every clinical format. Direct Message Care is unavailable for some conditions in some states, and scheduled GLP-1 care generally depends on access to a One Medical office or eligible remote appointment. Confirm whether your state offers messaging, video, scheduled remote care, or requires an in-person visit. Next, obtain separate prices for the clinical service, medication, and required labs. Ask whether the displayed $39 price applies to an initial assessment, renewal, or both; what later treatment requests cost; and how frequently the clinician expects follow-up. At the pharmacy, compare the insurance and cash prices for the exact prescribed brand and presentation. The lowest advertised prices may rely on manufacturer coupons that exclude people eligible for Medicare, Medicaid, TRICARE, or other government programs and can expire or change. If using insurance, verify that One Medical is in network at the selected location, then check the medication formulary, prior-authorization criteria, deductible, and expected copay. On-Demand Care does not submit prior authorizations, while scheduled primary care may. Finally, inspect the prescription and package for the exact FDA-approved brand if avoiding compounded medication is important. Recheck every price and availability claim immediately before purchase.

One Medical is a credible fit for adults who specifically want FDA-approved brand medication and value a recognizable primary-care organization. The cash-pay pathway may suit someone who wants a straightforward clinician review, already expects to pay for medication without insurance, and does not need prior-authorization assistance. The scheduled pathway is better aligned with people near a One Medical office who want weight management connected to ongoing primary care, laboratory monitoring, cardiovascular or metabolic health, and insurance billing. It is less suitable for shoppers looking for one predictable all-inclusive monthly price. The advertised starting figures omit medication, laboratories, and possible repeat treatment requests, while scheduled appointments can generate copays or deductible charges. It is also not a match for people specifically seeking compounded semaglutide or tirzepatide, because One Medical says it will not prescribe compounded GLP-1 products through On-Demand Care. The online route may not fit people outside its advertised 18–64 age range, people with diabetes, those who cannot provide the required laboratory results, or anyone whose history requires closer in-person management. It is also a weak choice for an insured patient who needs prior authorization but cannot access the scheduled primary-care pathway. State restrictions may further narrow the available formats. The central trade-off is flexibility versus price certainty: One Medical provides multiple care routes and brand-name options, but readers must assemble and verify the total cost themselves.